Cargando…
A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis
BACKGROUND: Ulcerative colitis (UC) is a chronic autoimmune inflammation of the colon. The condition significantly decreases quality of life and generates a substantial economic burden for healthcare payers, patients and the society in which they live. Some patients require chronic pharmacotherapy,...
Autores principales: | Stawowczyk, Ewa, Kawalec, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840213/ https://www.ncbi.nlm.nih.gov/pubmed/29260508 http://dx.doi.org/10.1007/s40273-017-0601-6 |
Ejemplares similares
-
Cost-effectiveness of biological treatment of ulcerative colitis – a systematic review
por: Stawowczyk, Ewa, et al.
Publicado: (2017) -
Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland
por: Kawalec, Paweł, et al.
Publicado: (2018) -
Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland
por: Kawalec, Paweł, et al.
Publicado: (2017) -
Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland
por: Stawowczyk, Ewa, et al.
Publicado: (2016) -
Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland
por: Stawowczyk, Ewa, et al.
Publicado: (2016)